Is a complete BCBA/AMGND research report available?

No complete published report is available for bcba/AMGND (BCBA/AMGND) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/AMGND (BCBA/AMGND)

Buenos Aires Stock Exchange: BCBA/AMGND · USD

$15.9

+0.30 (+1.9%)· Recorded snapshot

Market cap	372.1T
Revenue (ttm)	56.4T
Net income (ttm)	13T
EPS (ttm)	$824
P/E (trailing)	29.7x
P/E (forward)	18.9x
Dividend	$322 (1.31%)
Volume	150

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 56.4T
Net income (ttm): 13T
EPS (ttm): $824
P/E (trailing): 29.7x
P/E (forward): 18.9x
Market cap: 372.1T

Metric	Value
Amount currency	ARS
Country	United States
Country code	AR
Earnings date	2026-11-03
Employees	31,500
Employees change	3,500
Employees growth	12.5%
Enterprise value	$438.7T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-07-18
Fiscal year end	December
Founded	1980
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	ARDEUT110665
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Last stock split date	2024-01-24
Last stock split type	Forward
Market cap	$372.1T
Next earnings date	2026-11-03
Price	$15.93
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-27
Symbol	bcba/AMGND
Website	https://www.amgen.com

Metric

Value

Amount currency

ARS

Country

United States

Country code

Earnings date

2026-11-03

Employees

31,500

Employees change

3,500

Employees growth

12.5%

Enterprise value

$438.7T

Exchange

Buenos Aires Stock Exchange

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-07-18

Fiscal year end

December

Founded

1980

Industry

Drug Manufacturers - General

Is primary listing

ISIN number

ARDEUT110665

Last earnings date

2026-08-04

Last refreshed

2026-10-28

Last stock split date

2024-01-24

Last stock split type

Forward

Market cap

$372.1T

Next earnings date

2026-11-03

Price

$15.93

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-27

Symbol

bcba/AMGND

Website

https://www.amgen.com

Metric	Value
Average P/E ratio (10Y)	25.24x
Average P/E ratio (3Y)	29.44x
Average P/E ratio (5Y)	25.49x
Earnings yield	3.37%
EV/Earnings	33.9x
EV/EBIT	22.44x
EV/EBITDA	16.29x
EV/FCF	29.13x
EV/Sales	7.49x
FCF / EV yield	3.43%
FCF yield	4.05%
Forward P/E	18.88x
Graham number	3.03784
Graham upside	-80.93%
Lynch fair value	$4.85
Lynch upside	-69.55%
P/(FCF - SBC) ratio	25.97x
P/(OCF - SBC) ratio	20.98x
P/B ratio	21.51x
P/E ratio	29.69x
P/FCF ratio	24.71x
P/OCF ratio	20.15x
P/S ratio	6.6x
Price/EBITDA ratio	14.56x

Metric

Value

Average P/E ratio (10Y)

25.24x

Average P/E ratio (3Y)

29.44x

Average P/E ratio (5Y)

25.49x

Earnings yield

3.37%

EV/Earnings

33.9x

EV/EBIT

22.44x

EV/EBITDA

16.29x

EV/FCF

29.13x

EV/Sales

7.49x

FCF / EV yield

3.43%

FCF yield

4.05%

Forward P/E

18.88x

Graham number

3.03784

Graham upside

-80.93%

Lynch fair value

$4.85

Lynch upside

-69.55%

P/(FCF - SBC) ratio

25.97x

P/(OCF - SBC) ratio

20.98x

P/B ratio

21.51x

P/E ratio

29.69x

P/FCF ratio

24.71x

P/OCF ratio

20.15x

P/S ratio

6.6x

Price/EBITDA ratio

14.56x

Metric	Value
EBIT margin	33.4%
EBITDA margin	45.33%
Effective tax rate	15.01%
FCF margin	25.75%
Gross margin	71.89%
Operating margin	33.4%
Pretax margin	27%
Profit margin	22.95%
Profit per employee	$411.2M
Profitable quarters	9
Profitable years	23
Revenue per employee	$1.8B
ROA	8.67%
ROA (5Y)	8.22%
ROCE	18.14%
ROE	91.47%
ROE (5Y)	101.82%
ROIC	19.76%
ROIC (5Y)	20.52%
SBC / revenue	1.29%
Tax / revenue	4.05%

Metric

Value

EBIT margin

33.4%

EBITDA margin

45.33%

Effective tax rate

15.01%

FCF margin

25.75%

Gross margin

71.89%

Operating margin

33.4%

Pretax margin

27%

Profit margin

22.95%

Profit per employee

$411.2M

Profitable quarters

Profitable years

Revenue per employee

$1.8B

ROA

8.67%

ROA (5Y)

8.22%

ROCE

18.14%

ROE

91.47%

ROE (5Y)

101.82%

ROIC

19.76%

ROIC (5Y)

20.52%

SBC / revenue

1.29%

Tax / revenue

4.05%

Metric	Value
EPS growth	31.6%
EPS growth (Q)	64.91%
EPS growth (QoQ)	30.84%
EPS growth 10Y	5.12%
EPS growth 3Y	2.72%
EPS growth 5Y	10.3%
EPS growth quarters	6
EPS growth years	1
FCF growth	-4.06%
FCF growth (Q)	82.58%
FCF growth (QoQ)	136.22%
FCF growth 3Y	1.66%
FCF growth 5Y	2.72%
Gross profit growth	13.09%
Gross profit growth (Q)	12.23%
Gross profit growth 3Y	11.58%
Gross profit growth 5Y	7.36%
Net income growth	32.09%
Net income growth (Q)	65.85%
Net income growth (QoQ)	30.57%
Net income growth 3Y	3.09%
Net income growth 5Y	8.76%
Net income growth quarters	6
Net income growth years	1
OCF growth	3.87%
OCF growth (Q)	75.53%
OCF growth (QoQ)	82.82%
OCF growth 10Y	2.7%
OCF growth 3Y	4.93%
OCF growth 5Y	5.48%
Operating income growth	19.55%
Operating income growth (Q)	19.33%
Operating income growth 3Y	8.67%
Operating income growth 5Y	6.56%
Revenue growth	9.1%
Revenue growth (Q)	9.53%
Revenue growth (QoQ)	16.66%
Revenue growth 10Y	5.42%
Revenue growth 3Y	12.74%
Revenue growth 5Y	8.37%
Revenue growth quarters	13
Revenue growth years	6

Metric

Value

EPS growth

31.6%

EPS growth (Q)

64.91%

EPS growth (QoQ)

30.84%

EPS growth 10Y

5.12%

EPS growth 3Y

2.72%

EPS growth 5Y

10.3%

EPS growth quarters

EPS growth years

FCF growth

-4.06%

FCF growth (Q)

82.58%

FCF growth (QoQ)

136.22%

FCF growth 3Y

1.66%

FCF growth 5Y

2.72%

Gross profit growth

13.09%

Gross profit growth (Q)

12.23%

Gross profit growth 3Y

11.58%

Gross profit growth 5Y

7.36%

Net income growth

32.09%

Net income growth (Q)

65.85%

Net income growth (QoQ)

30.57%

Net income growth 3Y

3.09%

Net income growth 5Y

8.76%

Net income growth quarters

Net income growth years

OCF growth

3.87%

OCF growth (Q)

75.53%

OCF growth (QoQ)

82.82%

OCF growth 10Y

2.7%

OCF growth 3Y

4.93%

OCF growth 5Y

5.48%

Operating income growth

19.55%

Operating income growth (Q)

19.33%

Operating income growth 3Y

8.67%

Operating income growth 5Y

6.56%

Revenue growth

9.1%

Revenue growth (Q)

9.53%

Revenue growth (QoQ)

16.66%

Revenue growth 10Y

5.42%

Revenue growth 3Y

12.74%

Revenue growth 5Y

8.37%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-3.4T
Depreciation and amortization	$7T
EBIT	$18.9T
EBITDA	$25.6T
EPS	$824.30
Financing cash flow	$-6.1T
Free cash flow	$15.1T
Free cash flow minus SBC	$14.3T
Gross profit	$40.6T
Income taxes	$2.3T
Investing cash flow	$-3.5T
Net borrowing	$2T
Net cash flow	$8.8T
Net income	$13T
Operating cash flow minus SBC	$17.8T
Operating income	$18.9T
Revenue	$56.4T
Stock-based compensation	$728.9B

Metric

Value

Capital expenditures

$-3.4T

Depreciation and amortization

$7T

EBIT

$18.9T

EBITDA

$25.6T

EPS

$824.30

Financing cash flow

$-6.1T

Free cash flow

$15.1T

Free cash flow minus SBC

$14.3T

Gross profit

$40.6T

Income taxes

$2.3T

Investing cash flow

$-3.5T

Net borrowing

$2T

Net cash flow

$8.8T

Net income

$13T

Operating cash flow minus SBC

$17.8T

Operating income

$18.9T

Revenue

$56.4T

Stock-based compensation

$728.9B

Metric	Value
Altman Z-Score	1.89
Book value per share	$32,030.65
Debt / EBITDA	3.27
Debt / equity	4.9
Debt / FCF	5.63
Goodwill	$28.7T
Interest coverage	4.14
Long-term assets	$88T
Long-term liabilities	$85.2T
Net cash (debt)	$-64.2T
Net cash / market cap	-17.23%
Net debt / EBITDA	2.51
Net debt / equity	3.71
Net debt / FCF	4.26
Piotroski F-Score	8
Property, plant and equipment	$13.1T
Shareholders' equity	$17.3T
Tangible book value	$-40.7T
Tangible book value per share	$-75,272.59
Total assets	$141.7T
Total cash	$20.7T
Total debt	$84.9T
Total liabilities	$124.4T

Metric

Value

Altman Z-Score

1.89

Book value per share

$32,030.65

Debt / EBITDA

3.27

Debt / equity

4.9

Debt / FCF

5.63

Goodwill

$28.7T

Interest coverage

4.14

Long-term assets

$88T

Long-term liabilities

$85.2T

Net cash (debt)

$-64.2T

Net cash / market cap

-17.23%

Net debt / EBITDA

2.51

Net debt / equity

3.71

Net debt / FCF

4.26

Piotroski F-Score

Property, plant and equipment

$13.1T

Shareholders' equity

$17.3T

Tangible book value

$-40.7T

Tangible book value per share

$-75,272.59

Total assets

$141.7T

Total cash

$20.7T

Total debt

$84.9T

Total liabilities

$124.4T

Metric	Value
Asset turnover	0.42
Current assets	$53.7T
Current liabilities	$39.2T
Current ratio	1.37
Inventory turnover	1.67
Net working capital	$1.4T
Quick ratio	0.95
Working capital	$14T
Working capital turnover	7,181.74

Metric

Value

Asset turnover

0.42

Current assets

$53.7T

Current liabilities

$39.2T

Current ratio

1.37

Inventory turnover

1.67

Net working capital

$1.4T

Quick ratio

0.95

Working capital

$14T

Working capital turnover

7,181.74

Metric	Value
Buyback yield / dilution	-0.46%
Dividend growth	5.86%
Dividend growth (3Y)	6.07%
Dividend growth years	4
Dividend payment date	2026-09-11
Dividend payment years	6
Dividend payout frequency	Quarterly
Dividend per share	$321.62
Dividend yield	1.31%
Ex-dividend date	2026-08-21
Last dividend	$0.05
Payout ratio	60.45%
Shareholder yield	0.85%

Metric

Value

Buyback yield / dilution

-0.46%

Dividend growth

5.86%

Dividend growth (3Y)

6.07%

Dividend growth years

Dividend payment date

2026-09-11

Dividend payment years

Dividend payout frequency

Quarterly

Dividend per share

$321.62

Dividend yield

1.31%

Ex-dividend date

2026-08-21

Last dividend

$0.05

Payout ratio

60.45%

Shareholder yield

0.85%

Metric	Value
150-day SMA	$13.09
1D price change	1.92%
1M price change	10.86%
1M total return	10.86%
1W price change	5.71%
1W total return	5.71%
1Y price change	62.55%
1Y return CAGR	65.42%
1Y total return	65.37%
20-day SMA	$14.87
200-day SMA	$12.70
3M price change	24.75%
3M total return	25.2%
3Y price change	59.3%
3Y return CAGR	19.02%
3Y total return	68.6%
50-day SMA	$14.56
50-day SMA vs 200-day SMA	50over200
52-week high	$15.96
52-week high date	2026-10-27
52-week low	$9.01
52-week low date	2025-10-27
6M price change	34.43%
6M total return	35.56%
All-time high	$15.96
All-time high date	2026-10-27
All-time low	$6.95
All-time low date	2020-02-27
Average true range (ATR)	$0.31
Average volume	163
Change from 52-week high	-0.19%
Change from 52-week low	76.8%
Change from all-time high	-0.19%
Change from all-time low	129.21%
Change from open	1.34%
Day's gap	0.58%
Dollar volume	$2,390
High price	$15.96
Low price	$15.72
Monthly RSI	69.97
Open price	$15.72
Position in 52-week range	87.5%
Previous close	$15.63
Price vs 150-day SMA	21.71%
Price vs 20-day SMA	7.1%
Price vs 200-day SMA	25.43%
Price vs 50-day SMA	9.45%
Relative volume	0.92
RSI	65.96
Sharpe ratio	1.36
Sortino ratio	2.33
Volume	150
Weekly RSI	66.62
YTD price change	47.09%
YTD total return	48.98%

Metric

Value

150-day SMA

$13.09

1D price change

1.92%

1M price change

10.86%

1M total return

10.86%

1W price change

5.71%

1W total return

5.71%

1Y price change

62.55%

1Y return CAGR

65.42%

1Y total return

65.37%

20-day SMA

$14.87

200-day SMA

$12.70

3M price change

24.75%

3M total return

25.2%

3Y price change

59.3%

3Y return CAGR

19.02%

3Y total return

68.6%

50-day SMA

$14.56

50-day SMA vs 200-day SMA

50over200

52-week high

$15.96

52-week high date

2026-10-27

52-week low

$9.01

52-week low date

2025-10-27

6M price change

34.43%

6M total return

35.56%

All-time high

$15.96

All-time high date

2026-10-27

All-time low

$6.95

All-time low date

2020-02-27

Average true range (ATR)

$0.31

Average volume

163

Change from 52-week high

-0.19%

Change from 52-week low

76.8%

Change from all-time high

-0.19%

Change from all-time low

129.21%

Change from open

1.34%

Day's gap

0.58%

Dollar volume

$2,390

High price

$15.96

Low price

$15.72

Monthly RSI

69.97

Open price

$15.72

Position in 52-week range

87.5%

Previous close

$15.63

Price vs 150-day SMA

21.71%

Price vs 20-day SMA

7.1%

Price vs 200-day SMA

25.43%

Price vs 50-day SMA

9.45%

Relative volume

0.92

RSI

65.96

Sharpe ratio

1.36

Sortino ratio

2.33

Volume

150

Weekly RSI

66.62

YTD price change

47.09%

YTD total return

48.98%

Metric	Value
Float	539.2M
Shares change (QoQ)	0%
Shares change (YoY)	0.46%
Shares held by insiders	0.17%
Shares held by institutions	83.8%
Short ratio	4.8 days

Metric

Value

Float

539.2M

Shares change (QoQ)

Shares change (YoY)

0.46%

Shares held by insiders

0.17%

Shares held by institutions

83.8%

Short ratio

4.8 days

BCBA/AMGND (BCBA/AMGND)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/AMGND

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/AMGND indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/AMGND

Frequently asked questions